Your browser doesn't support javascript.
loading
ß-Elemene inhibits the metastasis of multidrug-resistant gastric cancer cells through miR-1323/Cbl-b/EGFR pathway.
Deng, Mingming; Liu, Bofang; Song, Huicong; Yu, Ruoxi; Zou, Dan; Chen, Yang; Ma, Yanju; Lv, Fei; Xu, Ling; Zhang, Zhe; Lv, Qingjie; Yang, Xianghong; Che, Xiaofang; Qu, Xiujuan; Liu, Yunpeng; Zhang, Ye; Hu, Xuejun.
Afiliação
  • Deng M; Department of Respiratory and Infectious Disease of Geriatrics, the First Hospital of China Medical University, Shenyang 110001, China; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China; Graduate School of Pekin
  • Liu B; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China; Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, Zhejiang, China.
  • Song H; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.
  • Yu R; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.
  • Zou D; The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang 110001, China.
  • Chen Y; Department of Respiratory and Infectious Disease of Geriatrics, the First Hospital of China Medical University, Shenyang 110001, China.
  • Ma Y; Department of Medical Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang 110042, China.
  • Lv F; The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang 110001, China.
  • Xu L; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.
  • Zhang Z; Department of Pathology, Shengjing Hospital of China Medical University, Shenyang 110001, China.
  • Lv Q; Department of Pathology, Shengjing Hospital of China Medical University, Shenyang 110001, China.
  • Yang X; Department of Pathology, Shengjing Hospital of China Medical University, Shenyang 110001, China.
  • Che X; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.
  • Qu X; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.
  • Liu Y; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.
  • Zhang Y; The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang 110001, China. Electronic address: yzhang21@cmu.edu.cn.
  • Hu X; Department of Respiratory and Infectious Disease of Geriatrics, the First Hospital of China Medical University, Shenyang 110001, China. Electronic address: huxuejun2015@126.com.
Phytomedicine ; 69: 153184, 2020 Apr.
Article em En | MEDLINE | ID: mdl-32199253
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Estomago Base de dados: MEDLINE Assunto principal: Sesquiterpenos / Neoplasias Gástricas / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Fitogênicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Phytomedicine Assunto da revista: TERAPIAS COMPLEMENTARES Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Estomago Base de dados: MEDLINE Assunto principal: Sesquiterpenos / Neoplasias Gástricas / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Fitogênicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Phytomedicine Assunto da revista: TERAPIAS COMPLEMENTARES Ano de publicação: 2020 Tipo de documento: Article